Growing scope of Oregon psilocybin program raises safety concerns, study says

A recent study by Johns Hopkins University highlights growing concerns about the safety of Oregon's pioneering psilocybin program. The initiative, initially designed for strictly medical use, now appears to be reaching a broader audience, potentially including individuals who may not be appropriate candidates. The findings published in the International Journal of Drug Policy suggest that the program's expansion could be putting more people at risk than previously thought. This development is significant because it raises questions about the oversight and regulation of such therapeutic programs, especially as other states consider similar legislation.